Notably, we also identified a strong positive correlation between ACE2 and BRCA-DRGs (R = 0.858, P = 8.25e−08) (Fig. 8F), indicating that ACE2 may be involved in regulating drug resistance in breast cancer. The gene discussed is ACE2; the disease is breast cancer.